Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
CEBPA
Name:
CCAAT enhancer binding protein alpha
Location:
19q13.11
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT00958555 | A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer | View | |
| NCT01296178 | PETHEMA-LMA10 Treatment of Acute Myeloblastic Leukemia AML in Patients Less Than or Equal to 65 Years | View | |
| NCT02428543 | Ponatinib for FLT3-ITD Acute Myelogenous Leukemia | View | |
| NCT05339204 | The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission | View | |
| NCT01100840 | A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer | View | |
| NCT01619501 | Dysregulation of the CEBPa Pathway in Human Lung Cancer and Search for New Biomarkers andor Therapeutic Targets | View | |
| NCT02716012 | First-in-Human Safety Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer | View | |
| NCT05097911 | Phase I Study of RNA Oligonucleotide MTL-CEBPA Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma | View | |
| NCT04311060 | Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia a Prospective Multicentric Study | View | |
| NCT04415008 | Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia | View | |
| NCT04710641 | Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone | View | |
| NCT06529250 | Intermediate-dose HAD Regimen for CEBPA Double-mutated AML | View | |
| NCT01057199 | Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia | View | |
| NCT06458257 | The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia | View | |
| NCT03311815 | Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing NGS in Patients Diagnosed With Acute Myeloid Leukemia | View | |
| NCT04105335 | A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours TIMEPOINT | View |